MRI-derived brain aging trajectories across the Alzheimer's continuum: links to cognition, pathology and lifestyle risk factors
Kuhn, E.; Antopoulos, G.; Kleineidam, L.; Stark, M.; Roeske, S.; Hoffstaedter, F.; Waite, L.; Peters, O.; Hellmann-Regen, J.; Preis, L.; Gref, D.; Priller, J.; Spruth, E. J.; Gemenetzi, M.; Schneider, A.; Fliessbach, K.; Wiltfang, J.; Schott, B. H.; Maier, F.; Duezel, E.; Glanz, W.; Incesoy, E.; Yakupov, R.; Luesebrink, F.; Buerger, K.; Janowitz, D.; Stoecklein, S.; Perneczky, R.; Rauchmann, B.-S.; Teipel, S. J.; Kilimann, I.; Laske, C.; Sodenkamp, S.; Spottke, A.; Brosseron, F.; Ramirez, A.; Schmid, M. C.; Hetzer, S.; Dechent, P.; Jessen, F.; Eickhoff, S. B.; Patil, K. R.; Wagner, M.
Show abstract
Background: The brain age gap (BAG), the difference between neuroimaging-predicted and chronological age, captures inter-individual variation in brain aging. Although sensitive to Alzheimer's disease (AD) pathology, its longitudinal patterns across the clinical AD continuum and prognostic relevance remain unclear. Methods: 577 participants from the DELCODE cohort (>2,100 MRI scans) were analysed: healthy controls individuals (HC, N=202), and patients with subjective cognitive decline (SCD, N=248), mild cognitive impairment (N=93), and AD dementia (N=34). All underwent structural MRI, amyloid (Ab42/40) and phosphorylated tau181 assessment, and lifestyle-related dementia risk profiling (LIBRA). BAG was derived using brainageR. Associations with baseline cognition, cognitive decline, and clinical progression (up to eight years) were examined using mixed-effects and Cox models. Mediation analyses tested whether BAG accounted for LIBRA-cognition associations. Biomarker-related and clinical findings were replicated in ADNI (N=461). Findings: BAG showed excellent short-term reliability, increased stepwise across the clinical spectrum and was elevated in amyloid-positive SCD, but not in asymptomatic amyloid-positive HC. Longitudinal BAG increases were strongest in amyloid- and tau-positive participants (Ab+T+). Higher BAG was associated with poorer baseline cognition and predicted cognitive decline, with strongest effects in Ab+T+. All main findings replicated in ADNI. BAG was associated with LIBRA only in biomarker-negative participants and partly mediated associations with cognitive outcomes in DELCODE. Interpretation: BAG is a reliable non-invasive marker of structural brain health sensitive to AD pathology and to modifiable AD risk. Detectable divergence prior to objective cognitive impairment supports its relevance for early risk stratification and prevention-oriented research. Funding: Helmholtz AI Cooperation Unit (ZT-I-PF-5-163).
Matching journals
The top 6 journals account for 50% of the predicted probability mass.
Similar papers in this journal
- Association between telomere length and cognitive function among cognitively unimpaired individuals at risk of Alzheimer’s disease 96%
- Subtypes of brain change in aging and their associations with cognition and Alzheimer's disease biomarkers 96%
- Pupillary dilation responses as a midlife indicator of risk for Alzheimer’s Disease: Association with Alzheimer’s disease polygenic risk 95%
Similar papers in this journal
- Differential effects of aging, Alzheimer's pathology, and APOE4 on longitudinal functional connectivity and episodic memory in older adults 96%
- Continuum of Core 1 Biomarkers in Preclinical Alzheimers Disease 95%
- Early Syndecan-4 Upregulation Predicts Cognitive and Pathological Trajectories in Alzheimer Disease 95%
Similar papers in this journal
- Targeting age-related differences in brain and cognition with multimodal imaging and connectome topography profiling 96%
- Joint contributions of cortical morphometry and white matter microstructure in healthy brain aging: A partial least squares correlation analysis 95%
- A comprehensive score reflecting memory-related fMRI activations and deactivations as potential biomarker for neurocognitive aging 95%
Similar papers in this journal
- Genetic risk for Alzheimer disease, cognition and Mild Behavioral Impairment in healthy older adults 95%
- Association of a pace of aging epigenetic clock with rate of cognitive decline in the Framingham Heart Study Offspring Cohort 94%
- Delayed primacy recall performance predicts post mortem Alzheimers disease pathology from unimpaired ante mortem cognitive baseline 94%